fda compounding semaglutide warning letters october 2025 Out of Shortage, Into Controversy: The Fight Over GLP-1 February 17, 2026: Pennsylvania compounding
Description
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions.
PlexusDx provides transparent guidance on the evolving GLP-1 market and maintains supply of compounded semaglutide injection starting at $149/mo for eligible patients
Confused about semaglutide units
A case alleging Express Scripts Inc
And theyre not coming back to the novelty freezer the way they used to
IntroductionWeight loss is more than just willpower and dieting
